Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor. A genomics approach at the Medical University of South Carolina (MUSC) has unmasked genetic signatures in breast cancer cells that predict their sensitivity to certain drugs.

More at MUSC News